Unlabelled: Dematiaceous fungi are the etiological agents of phaeohyphomycosis. Diverse presentations of infectious syndromes are seen, ranging from local infections after trauma to widely disseminated infection in immunocompromised patients. Fonsecaea pedrosoi species have been reported to cause an increasing number of infections, particularly in severely immunocompromised patients. Colonization of normal skin has been reported. We present a case of F. pedrosoi osteomyelitis in an immunocompetent patient. A high level of suspicion and routine fungal cultures are required to identify these cases. Tissue culture and pathologic examination are necessary for definitive diagnosis and for distinguishing infection from colonization. Therapy includes antifungal drugs (itraconazole) and aggressive surgical debridement, and, even when these modalities are readily implemented, the outcome may not be optimal because of the angioinvasive character of the organism.
Level Of Clinical Evidence: 4.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.jfas.2009.05.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Development of PCR-Multiplex Assays for Identification of the Herpotrichiellaceae Family and Agents Causing Chromoblastomycosis.
J Fungi (Basel)
August 2024
Laboratório de Micoses Superficiais e Sistêmicas, Seção de Bacteriologia e Micologia, Instituto Evandro Chagas, Ananindeua 67030-000, Brazil.
Article Synopsis
- The Herpotrichiellaceae family consists of pathogenic fungi linked to diseases like chromoblastomycosis and phaeohyphomycosis, which present complex clinical symptoms and are found globally.
- Identifying these fungi is difficult due to subjective morphological methods, leading researchers to rely on molecular techniques, particularly genetic sequencing of ribosomal DNA.
- This study developed optimized PCR-Multiplex methodologies to improve the identification of these fungi, aiming to enhance infection management and provide more accurate epidemiological data.
Calcineurin activity in Fonsecaea pedrosoi: tacrolimus and cyclosporine A inhibited conidia growth, filamentation and showed synergism with itraconazole.
Braz J Microbiol
July 2024
Laboratório de Taxonomia, Bioquímica e Bioprospecção de Fungos (LTBBF), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, 21040-900, Brazil.
Article Synopsis
- * The researchers discovered calcineurin activity in F. pedrosoi and found it can be inhibited by drugs like FK506 and CsA, which led to cell death and visible changes in the fungal structure.
- * FK506 was the most effective treatment, with a lower required concentration to inhibit growth compared to CsA, and both drugs showed a synergistic effect when combined with itraconazole, highlighting calcineurin as a potential antifungal target.
Chromoblastomycosis in French Guiana: Epidemiology and Practices, 1955-2023.
J Fungi (Basel)
February 2024
Department of Dermatology, Andrée Rosemon Hospital, 97306 Cayenne, French Guiana.
Article Synopsis
- - Chromoblastomycosis (CBM) is a chronic fungal disease primarily found in tropical areas, with limited data on its occurrence in French Guiana from 1950 to 2023, where a study identified 23 mostly male patients, mainly of Creole descent.
- - The majority of cases presented lesions on the lower limbs and had a median diagnosis time of four years, with diagnostic methods including direct microscopy (78.3%) and mycological cultures (69.6%).
- - Treatment approaches varied, involving antifungals like itraconazole and terbinafine, surgery, or a combination of these, with surgery recommended for new, localized lesions, highlighting differences in CBM compared to other mycoses
Comparison of the antifungal activity of the pyrimidine analogs flucytosine and carmofur against human-pathogenic dematiaceous fungi.
Med Mycol
March 2024
Mycology Laboratory, National Institute of Infectious Diseases Evandro Chagas, INI/Fiocruz, Rio de Janeiro, Brazil.
Article Synopsis
- Chromoblastomycosis (CBM) and pheohyphomycosis (PHM) are fungal infections caused by dematiaceous fungi, with flucytosine (5-FC) historically used for treatment but often leading to resistance.
- This study evaluated carmofur, a related drug, showing it has higher selectivity and potential synergistic effects when used with other antifungals against certain fungal strains.
- While carmofur demonstrated some advantages in combating resistance, it also faced its own challenges, indicating the need for careful consideration in its clinical use alongside other treatments.
Identification of Chromoblastomycosis and Phaeohyphomycosis Agents through ITS-RFLP.
J Fungi (Basel)
February 2024
Laboratório de Micoses Superficiais e Sistêmicas, Seção de Bacteriologia e Micologia, Instituto Evandro Chagas, Ananindeua 67030-000, Brazil.
Chromoblastomycosis (CBM) and phaeohyphomycosis (FEO) are infections caused by melanized filamentous fungal agents, primarily found in tropical and subtropical regions. Both infections pose significant challenges for the correct identification of the causative agent due to their morphological similarity, making conventional methods of morphological analysis highly subjective. Therefore, molecular techniques are necessary for the precise determination of these species.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!